INS and cancer: We found that most cancer cell lines co-cultured with CRISPRa-AAV-treated adipocytes showed a significant reduction in both basal and maximal glycolytic rate (Fig. 1e,f) and lower glucose uptake in both basal and insulin conditions (Fig. 1g,h).